Yvonne Henskens

Associate professor

Dr Yvonne Henskens graduated with the specialisations in Biochemistry and Toxicology at Wageningen University. She worked on salivary cystatins in periodontal health and disease at the Department of Oral Biochemistry, Free University Amsterdam/Academic Centre for Dentistry (ACTA). After her PhD she started her specialisation for Clinical Chemistry at the Reinier de Graaf Gasthuis in Delft.

At this moment she is a clinical biochemist, working in laboratories for the past 15 years (Amsterdam Medical Centre and Maastricht UMC+). She has been responsible for the diagnostic tests concerning hematology, hemostasis and transfusion at Maastricht UMC+ since 2003. She has special research interest in laboratory predictors of bleeding and in pre- and peri-operative management of coagulopathies: Active in the boards of the Dutch societies for hematologicallaboratories and clinical chemistry. Involved in training and education of medical and life sciences students, laboratory technicians and residents. Founder of a re-training programme on hemostasis and transfusion for technicians and clinical biochemists for the south-east part of the Netherlands.

Central Diagnostic Laboratory MUMC+
Department of Biochemistry
P. Debyelaan 25, 6229 HX Maastricht
Room number: 5.E2.001
T: +31(0)43 387 79 76

2024
- Jooss, N. J., Diender, M. G., Fernandez, D. I., Huang, J., Heubel-Moenen, F. C. J., van der Veer, A., Kuijpers, M. J. E., Poulter, N. S., Henskens, Y. M. C., te Loo, M., & Heemskerk, J. W. M. (2024). Restraining of glycoprotein VI- and integrin a2ß1-dependent thrombus formation by platelet PECAM1. Cellular and Molecular Life Sciences, 81(1), Article 44. https://doi.org/10.1007/s00018-023-05058-2
- Gulikers, J. L., Otten, L.-S., Hendriks, L. E. L., Winckers, K., Henskens, Y., Leentjens, J., van den Heuvel, M. M., Ter Heine, R., Croes, S., Piet, B., & van Geel, R. M. J. M. (2024). Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British Journal of Cancer, 131(3), 481-490. https://doi.org/10.1038/s41416-024-02744-1
- Haisma, B., Schols, S. E. M., van Oerle, R. G. M., Verbeek-Knobbe, K., Hellenbrand, D., Verwoerd, E. J., Heubel-Moenen, F. C. J. I., Stroobants, A. K., Meijer, D., Rijpma, S. R., & Henskens, Y. M. C. (2024). Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment. Thrombosis Research, 240, Article 109045. https://doi.org/10.1016/j.thromres.2024.109045
- Meier, R. T., Porcelijn, L., Hofstede-van Egmond, S., Henskens, Y. M. C., Coutinho, J. M., Kruip, M. J. H. A., Stroobants, A. K., Zwaginga, J. J., van der Bom, J. G., van der Schoot, C. E., de Haas, M., & Kapur, R. (2024). Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands. Vox sanguinis, 119(7), 728-736. https://doi.org/10.1111/vox.13633
- Baker, R. I., Choi, P., Curry, N., Gebhart, J., Gomez, K., Henskens, Y., Heubel-Moenen, F., James, P., Abdul Kadir, R., Kouides, P., Lavin, M., Lordkipanidze, M., Lowe, G., Mumford, A., Mutch, N., Nagler, M., Othman, M., Pabinger, I., Sidonio, R., ... ISTH SSC Von Willebrand Factor, Platelet Physiology and Women’s Health Issues in Thrombosis and Haemostasis. (2024). Standardization of definition and management for bleeding disorder of unknown cause: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 22(7), 2059-2070. https://doi.org/10.1016/j.jtha.2024.03.005
- de Jong, M. J., Saadan, H., Hellenbrand, D. L. S., Ten Cate, H., Spaetgens, B., Brüggemann, R. A. G., van Kuijk, S. M. J., Winckers, K., Henskens, Y. M. C., & Magdelijns, F. J. H. (2024). The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: An exploratory study. Journal of the American Geriatrics Society, 72(7), 2249-2253. https://doi.org/10.1111/jgs.18894
- Meier, R. T., Porcelijn, L., Hofstede-van Egmond, S., Caram-Deelder, C., Coutinho, J. M., Henskens, Y. M. C., Kruip, M. J. H. A., Stroobants, A. K., Zwaginga, J. J., van der Schoot, C. E., de Haas, M., & Kapur, R. (2024). Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients. ANTIBODIES, 13(2), Article 35. https://doi.org/10.3390/antib13020035
- Vroemen, W. H. M., Denessen, E. J. S., van Doorn, W. P. T. M., Pelzer, K. E. J. M., Hackeng, T. M., Litjens, E. J. R., Henskens, Y. M. C., van der Sande, F. M., Wodzig, W. K. W. H., Kooman, J. P., Bekers, O., de Boer, D., & Mingels, A. M. A. (2024). Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?Journal of Applied Laboratory Medicine. Advance online publication. https://doi.org/10.1093/jalm/jfae052
- Hulshof, A. M., Nab, L., van Rosmalen, F., de Kok, J., Mulder, M. M. G., Hellenbrand, D., Sels, J. W. E. M., ten Cate, H., Cannegieter, S. C., Henskens, Y. M. C., & van Bussel, B. C. T. (2024). Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort. Thrombosis Research, 234, 51-58. https://doi.org/10.1016/j.thromres.2023.12.010
2023
- Mulder, M. M. G., Schellens, J., Sels, J.-W. E. M., van Rosmalen, F., Hulshof, A.-M., de Vries, F., Segers, R., Mihl, C., van Mook, W. N. K. A., Bast, A., Spronk, H. M. H., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Schurgers, L. J., Drent, M., & van Bussel, B. C. T. (2023). Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort. Journal of Intensive Care, 11(1), Article 63. https://doi.org/10.1186/s40560-023-00712-0

Overview

Latest news & events

ZonMw grant Middellange termijn effecten van COVID-19 maatregelen

20 August 2024

Professorship Henri Spronk

12 August 2024

Yvonne Henskens

Associate professor